glp-1 cons 2026 Employee Benefits Trends: Should You Cover GLP‑1s for Weight Loss? Is Ozempic Actually The Best
Description
Most likely
This behavior leads to mindless eating and can cause unnecessary weight accumulation
Semaglutide Semaglutide is a GLP-1 receptor agonist that is dosed once a week subcutaneously based on its extended half-life
The sublingual options are priced lower than the injectable versions on the Direct Meds platform
A slightly better case can save you stress and help protect medications that are expensive and sensitive
Patients who are not obese, or indeed underweight, will still experience weight loss on these medications, so that needs to be balanced with any other potential health benefit.
